Novoray Corporation (688300) - Total Liabilities

Latest as of September 2025: CN¥585.16 Million CNY ≈ $85.63 Million USD

Based on the latest financial reports, Novoray Corporation (688300) has total liabilities worth CN¥585.16 Million CNY (≈ $85.63 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Novoray Corporation - Total Liabilities Trend (2012–2024)

This chart illustrates how Novoray Corporation's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Novoray Corporation to evaluate short-term liquidity relative to the company's equity base.

Novoray Corporation Competitors by Total Liabilities

The table below lists competitors of Novoray Corporation ranked by their total liabilities.

Company	Country	Total Liabilities
Oshkosh Corporation NYSE:OSK	USA	$5.30 Billion
Jfrog Ltd NASDAQ:FROG	USA	$449.21 Million
MOWI ASA SP.ADR F:PNDA	Germany	€5.66 Billion
Israel Discount Bank Ltd TA:DSCT	Israel	ILA437.36 Billion
Ecopro BM. Co. Ltd KQ:247540	Korea	₩2.66 Trillion
Xpeng Inc NYSE:XPEV	USA	$72.08 Billion
Nordnet AB ST:SAVE	Sweden	Skr314.90 Billion
Godaddy Inc NYSE:GDDY	USA	$7.92 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Novoray Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Novoray Corporation worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Novoray Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Novoray Corporation (2012–2024)

The table below shows the annual total liabilities of Novoray Corporation from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥464.29 Million ≈ $67.94 Million	+14.00%
2023-12-31	CN¥407.26 Million ≈ $59.60 Million	+32.40%
2022-12-31	CN¥307.59 Million ≈ $45.01 Million	+45.64%
2021-12-31	CN¥211.19 Million ≈ $30.90 Million	+64.20%
2020-12-31	CN¥128.62 Million ≈ $18.82 Million	+0.82%
2019-12-31	CN¥127.58 Million ≈ $18.67 Million	+35.45%
2018-12-31	CN¥94.19 Million ≈ $13.78 Million	-14.46%
2017-12-31	CN¥110.11 Million ≈ $16.11 Million	+35.19%
2016-12-31	CN¥81.45 Million ≈ $11.92 Million	+11.95%
2015-12-31	CN¥72.76 Million ≈ $10.65 Million	-10.24%
2014-12-31	CN¥81.05 Million ≈ $11.86 Million	-28.12%
2013-12-31	CN¥112.77 Million ≈ $16.50 Million	+146.34%
2012-12-31	CN¥45.78 Million ≈ $6.70 Million	--

About Novoray Corporation

SHG:688300 China Specialty Chemicals

Market Cap

$9.54 Billion

CN¥65.19 Billion CNY

Market Cap Rank

#2342 Global

#290 in China

Share Price

CN¥269.99

Change (1 day)

+9.50%

52-Week Range

CN¥44.70 - CN¥272.54

All Time High

CN¥272.54